These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 33913422)
21. Pharmacological management of cannabinoid hyperemesis syndrome: an update of the clinical literature. Burillo-Putze G; Richards JR; Rodríguez-Jiménez C; Sanchez-Agüera A Expert Opin Pharmacother; 2022 Apr; 23(6):693-702. PubMed ID: 35311429 [TBL] [Abstract][Full Text] [Related]
22. Cannabinoid hyperemesis syndrome: a cause of refractory nausea and vomiting in pregnancy. Alaniz VI; Liss J; Metz TD; Stickrath E Obstet Gynecol; 2015 Jun; 125(6):1484-1486. PubMed ID: 25774930 [TBL] [Abstract][Full Text] [Related]
23. Management of Cannabinoid Hyperemesis Syndrome: Focus on Capsaicin. Stumpf JL; Williams LD J Pharm Pract; 2021 Oct; 34(5):786-793. PubMed ID: 32613883 [TBL] [Abstract][Full Text] [Related]
24. Cannabinoid hyperemesis acute renal failure: a common sequela of cannabinoid hyperemesis syndrome. Habboushe J; Sedor J Am J Emerg Med; 2014 Jun; 32(6):690.e1-2. PubMed ID: 24418446 [TBL] [Abstract][Full Text] [Related]
25. Capsaicin Cream for Treatment of Cannabinoid Hyperemesis Syndrome in Adolescents: A Case Series. Graham J; Barberio M; Wang GS Pediatrics; 2017 Dec; 140(6):. PubMed ID: 29122973 [TBL] [Abstract][Full Text] [Related]
26. [Cannabinoid hyperemesis as a differential diagnosis of nausea and vomiting in the emergency department]. Korn F; Hammerich S; Gries A Anaesthesist; 2021 Feb; 70(2):158-160. PubMed ID: 33090239 [TBL] [Abstract][Full Text] [Related]
27. Emergency Department Treatment of Cannabinoid Hyperemesis Syndrome: A Review. Khattar N; Routsolias JC Am J Ther; 2018; 25(3):e357-e361. PubMed ID: 28953512 [TBL] [Abstract][Full Text] [Related]
29. Cannabinoid hyperemesis syndrome: an underreported entity causing nausea and vomiting of pregnancy. Schmid SM; Lapaire O; Huang DJ; Jürgens FE; Güth U Arch Gynecol Obstet; 2011 Nov; 284(5):1095-7. PubMed ID: 21170540 [TBL] [Abstract][Full Text] [Related]
30. Cannabinoid hyperemesis syndrome: a case report and review of pathophysiology. Iacopetti CL; Packer CD Clin Med Res; 2014 Sep; 12(1-2):65-7. PubMed ID: 24667219 [TBL] [Abstract][Full Text] [Related]
31. Haloperidol, a Novel Treatment for Cannabinoid Hyperemesis Syndrome. Witsil JC; Mycyk MB Am J Ther; 2017; 24(1):e64-e67. PubMed ID: 25393073 [TBL] [Abstract][Full Text] [Related]
32. Recurring vomiting, skin discolouration: the easily overlooked thermal element of cannabinoid hyperemesis syndrome. Ali AA; Mathew R; Maaliki N; Shelley P BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33762293 [No Abstract] [Full Text] [Related]
33. Treatment of Cannabis Hyperemesis Syndrome Using Haloperidol in a Pregnant Patient: Case Report. La Sala MS; Constantino E; Koola MM; Yel I; Chacko M J Clin Psychopharmacol; 2022 Sep-Oct 01; 42(5):506-508. PubMed ID: 35943399 [No Abstract] [Full Text] [Related]
34. Cannabinoid Hyperemesis Syndrome in Pediatrics: An Emerging Problem. Dosani K; Koletic C; Alhosh R Pediatr Rev; 2021 Sep; 42(9):500-506. PubMed ID: 34470869 [TBL] [Abstract][Full Text] [Related]